Chris@NNW, Author at NetworkNewsWire

ThursdayFeb 20, 2020 12:01 pm

SinglePoint Inc. (SING) Subsidiary Reports Continued Growth as Company Kicks Off 2020 Initiatives

SING’s current strategy includes focused marketing, sales-development initiatives Company “strongly committed” to continued development, improvement of Direct Solar America subsidiary SEIA dubs 2020s the solar+ decade; SING set to capitalize on solar becoming leading source of new-energy generation Following a week during which its subsidiary Direct Solar America reported increased growth in terms of new contract development, SinglePoint Inc. (OTCQB: SING) notes that the company’s 2020 strategy – which includes new marketing and sales development initiatives – is starting to take shape (http://nnw.fm/Bd4cQ). Designed primarily around Direct Solar America, those initiatives are comprised of starting new canvassing teams, improving customer…

ThursdayFeb 20, 2020 11:04 am

National Storm Recovery Inc. (NSRI) is “One to Watch”

More than 40 years of next level experience with mulch manufacturing, colorant production, product innovation and treating/caring for trees and tree debris recycling. Services include tree removal, trimming, grapple hauling, land clearing, stump grinding, mulch processing, colorant production and packaging, transportation and distribution. Acquisition of Mulch Manufacturing provides NSRI a significantly larger footprint nationally and abroad. Mulch Manufacturing maintains its historical contracts with big box retailers nationally for bagged mulch sales. NSRI benefits from a competitive advantage over other mulch manufacturers because the acquisition of mulch feedstock drives revenue instead of simply being a cost of goods sold. Environmentally responsible…

WednesdayFeb 19, 2020 11:41 am

Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary Advances Precision Therapeutics by Learning Cancer Behavior, Improving Outcomes

Predictive Oncology subsidiary TumorGenesis developing faster, less costly and more accurate PDx cancer models that better mimic patient’s tumor TumorGenesis revolutionary technology will provide pharmaceuticals with quicker, more effective drug development while significantly improving patient outcomes POAI to begin sales of TumorGenesis’ innovative culture media in the first half of 2020 TumorGenesis, a flagship subsidiary of Predictive Oncology Inc. (NASDAQ: POAI), has made concrete steps in identifying and separating cancer-related biomarkers, which is likely to speed the development of new and effective therapeutics. TumorGenesis media are specially formulated to help researchers isolate and maintain the unique histological and basic biological…

WednesdayFeb 19, 2020 11:04 am

Trxade Group Inc. (NASDAQ: MEDS) Uplists to Nasdaq, Expects Gross Proceeds of $5.2M from Common Stock Sale

Trxade announces pricing of a firm commitment public offering of 806,452 shares of its common stock Proceeds to be used as working capital and to fund future acquisitions Company’s B2B online purchasing platform currently has 11,900 pharmacies registered and is registering 100+ New pharmacies per month Trxade Group Inc. (NASDAQ: MEDS), an integrated drug delivery, procurement, and healthcare platform that offers healthcare buyers and sellers of pharmaceuticals increased profit margins, announced that its common stock has begun trading on the Nasdaq Capital Market under new ticker symbol ‘MEDS’, as of February 13, 2020. The company’s common stock will cease trading…

WednesdayFeb 19, 2020 10:11 am

Sharing Services Global Corporation (SHRG) Supporting, Empowering Elepreneurs through Happiness Conference

Sharing Services Global Corporation offers entrepreneurial opportunities, broad range of products and services for contemporary consumers SHRG will be holding the Happiness Revolution Convention 2020 this spring Sharing Services Global facilitates Blue Ocean Strategy, symbolic of immense opportunity in the entrepreneurial space Sharing Services Global Corporation (OTCQB: SHRG) is a holding company that owns, operates or controls an interest in companies specializing in the direct-selling industry. The company’s emphasis is on direct selling, and SHRG has grown by thousands of independent sales representatives over the past year. Through one of its strategic avenues to help empower its growing body of…

WednesdayFeb 19, 2020 9:00 am

Indonesia Consolidates Nickel Production to Feed Growing EV Battery Market

NetworkNewsWire Editorial Coverage: Demand for electric vehicle batteries is pushing up production of nickel, especially in Indonesia, where the government is moving to benefit from its natural resources. One of the companies on the leading edge of this upward momentum is Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) (PCRCF Profile), which is setting out a bold expansion plan following a successful exploration and development season in Indonesia last year. Other companies with interest in nickel production include Honda Motor Company Ltd. (NYSE: HMC) (OTC: HNDAF), which will be looking for more nickel as it increases its EV…

TuesdayFeb 18, 2020 3:00 pm

Summit Wireless Technologies Inc. (NASDAQ: WISA) Starts Presentation at NobleCon16

Summit Wireless Technologies (NASDAQ: WISA) is a provider of immersive, wireless sound technology for intelligent devices and next generation home entertainment systems. Working with leading CE brands and manufacturers such as Harman International, a division of Samsung, LG Electronics, Klipsch, Bang & Olufsen, Xbox, a subsidiary of Microsoft, and others, Summit Wireless delivers seamless, dynamic audio experiences for high-definition content, including movies and video, music, sports, gaming/esports and more. Summit Wireless is a founding member of WiSA, the Wireless Speaker and Audio Association and works in joint partnership to champion the most reliable interoperability standards across the audio industry. Summit…

TuesdayFeb 18, 2020 3:00 pm

ImmunoPrecise Antibodies Ltd. (TSX.V: IPA) (OTCQB: IPATF) Starts Presentation at NobleCon16

ImmunoPrecise (TSX.V: IPA) (OTCQB: IPATF) is an international, full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell Select™ progressive single-cell interrogation technology and the DeepDisplay™ custom, OmniAb®-based phage libraries, as well as the Abthena™ bispecific program. ImmunoPrecise discovery and development are conducted in Utrecht and Oss, the Netherlands (U-Protein Express and IPA Europe, respectively), and in Victoria, British Columbia (IPA Canada). The company operates globally to offer a continuum of superior antibody services, transforming the face of therapeutic discovery, by decreasing turnaround time and risk, and promoting clinical success. For more information, visit the company’s…

TuesdayFeb 18, 2020 3:00 pm

OncoSec Medical Inc. (NASDAQ: ONCS) Starts Presentation at NobleCon16

OncoSec Medical (NASDAQ: ONCS) is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer. OncoSec has built a deep and diverse clinical pipeline utilizing its primary technology, TAVO™ (tavokinogene telseplasmid), as a potential treatment for multiple cancer indications, either as a monotherapy or in combination with leading checkpoint inhibitors. The latter potentially enables OncoSec to address a great unmet medical need in oncology: anti-PD-1 non- responders. OncoSec is also identifying and developing new DNA-encoded therapeutic candidates and tumor indications for use with its new Visceral Lesion Applicator (VLA), to…

TuesdayFeb 18, 2020 2:30 pm

Xenetic Biosciences Inc. (NASDAQ: XBIO) Starts Presentation at NobleCon16

Xenetic Biosciences (NASDAQ: XBIO) is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a robust pipeline of therapeutic assets targeting high-value oncology indications. Additionally, Xenetic is leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. PolyXen has demonstrated its ability to improve the half-life and other pharmacological properties of next-generation…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Author: Chris@NNW

SinglePoint Inc. (SING) Subsidiary Reports Continued Growth as Company Kicks Off 2020 Initiatives

National Storm Recovery Inc. (NSRI) is “One to Watch”

Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary Advances Precision Therapeutics by Learning Cancer Behavior, Improving Outcomes

Trxade Group Inc. (NASDAQ: MEDS) Uplists to Nasdaq, Expects Gross Proceeds of $5.2M from Common Stock Sale

Sharing Services Global Corporation (SHRG) Supporting, Empowering Elepreneurs through Happiness Conference

Indonesia Consolidates Nickel Production to Feed Growing EV Battery Market

Summit Wireless Technologies Inc. (NASDAQ: WISA) Starts Presentation at NobleCon16

ImmunoPrecise Antibodies Ltd. (TSX.V: IPA) (OTCQB: IPATF) Starts Presentation at NobleCon16

OncoSec Medical Inc. (NASDAQ: ONCS) Starts Presentation at NobleCon16

Xenetic Biosciences Inc. (NASDAQ: XBIO) Starts Presentation at NobleCon16

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search